Device Trial Radar · NCT06368193
The Neuralert Stroke Monitor Pilot Trial
Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
50
Planned (sponsor's estimate)
Start
Dec 12, 2024
Primary completion
Nov 14, 2027
Study completion Nov 14, 2028
Sponsor
- Lead sponsor
- Neuralert Technologies LLCNot on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 16, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This trial aims to demonstrate that the Neuralert Monitoring System will detect strokes before they would be identified by current standard of care. Each patient will be monitored for up to five days, depending on device connectivity or battery duration. Each monitoring session will consist of wearing a Neuralert device on each arm. For this pilot trial, we are interested in learning about Wi-Fi connectivity, successful data transmission, integration into clinical workflow, usability and tolerability.
Conditions
- Stroke
- Surgery
Interventions
Neuralert MonitorDevice
Device to identify upper extremity asymmetry in patients who are high risk for stroke.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to Nursing ResponseTime frame: Up to 5 days post patient surgery
- Time to Generate AlertTime frame: Up to 5 days post patient surgery
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.